Authors: Hancock, BW Gregory, WM Cullen, MH Hudson, GV Burton, A Selby, P Maclennan, KA Jack, A Bessell, EM Smith, P Linch, DC

Citation: Bw. Hancock et al., ChlVPP alternating with PABIOE is superior to PABIOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trial, BR J CANC, 84(10), 2001, pp. 1293-1300

Authors: Linch, DC Smith, P Hancock, BW Hoskin, PJ Cunningham, DC Newland, AC Milligan, D Stevenson, PA Wood, JK Maclennan, KA Hudson, BV Hudson, GV Gregory, WM

Citation: Dc. Linch et al., A randomised British National Lymphoma Investigation trial of CHOP vs. a weekly multi-agent regimen (PACEBOM) in patients with histologically aggressive non-Hodgkin's lymphoma, ANN ONCOL, 11, 2000, pp. 87-90

Authors: Nathwani, BN Anderson, JR Armitage, JO Cavalli, F Diebold, J Drachenberg, MR Harris, NL Maclennan, KA Muller-Hermelink, HK Ullrich, FA Weisenburger, DD

Citation: Bn. Nathwani et al., Clinical significance of follicular lymphoma with monocytoid B cells, HUMAN PATH, 30(3), 1999, pp. 263-268